Cargando…

A Cardio-Oncology Cardiovascular Prevention Framework

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Marvel, Françoise A., Whelton, Seamus P., Blumenthal, Roger S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	State-of-the-Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352031/ https://www.ncbi.nlm.nih.gov/pubmed/34396187 http://dx.doi.org/10.1016/j.jaccao.2019.11.012

Ejemplares similares

Summarizing 2019 in Cardiovascular Prevention using the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease’s ‘ABC’s Approach
por: Feldman, David I., et al.
Publicado: (2020)

The Johns Hopkins Ciccarone Center's expanded ‘ABC's approach to highlight 2020 updates in cardiovascular disease prevention
por: Feldman, David I., et al.
Publicado: (2021)

Birth and Maturation of Cardio-Oncology
por: Bhatt, Deepak L.
Publicado: (2019)

Advancing Cardio-Oncology in Asia
por: Ng, Choon Ta, et al.
Publicado: (2022)

COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities
por: Ky, Bonnie, et al.
Publicado: (2020)

COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities
por: Ky, Bonnie, et al.
Publicado: (2020)

Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology
por: Lenihan, Daniel J., et al.
Publicado: (2019)

Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review
por: Li, Yimei, et al.
Publicado: (2022)

Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technology
por: Javaid, Aamir, et al.
Publicado: (2022)

Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: JACC: CardioOncology State-of-the-Art Review
por: Wilson, Rebekah L., et al.
Publicado: (2023)

Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review
por: Quartermaine, Cooper, et al.
Publicado: (2023)

The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity
por: Minasian, Lori M., et al.
Publicado: (2019)

Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: JACC: CardioOncology State-of-the-Art Review
por: Parashar, Susmita, et al.
Publicado: (2023)

Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review
por: Georgiopoulos, Georgios, et al.
Publicado: (2023)

Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy: JACC CardioOncology State-of-the-Art Review
por: Harries, Iwan, et al.
Publicado: (2020)

Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art Review
por: Glen, Claire, et al.
Publicado: (2022)

Using Behavioral Economics and Technology to Improve Outcomes in Cardio-Oncology
por: Waddell, Kimberly J., et al.
Publicado: (2020)

Cardiac Tumors: JACC CardioOncology State-of-the-Art Review
por: Tyebally, Sara, et al.
Publicado: (2020)

Cardio-Oncology: Understanding the Intersections Between Cardiac Metabolism and Cancer Biology
por: Karlstaedt, Anja, et al.
Publicado: (2021)

Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review
por: Leerink, Jan M., et al.
Publicado: (2020)

Climate change and the prevention of cardiovascular disease
por: Jacobsen, Alan P., et al.
Publicado: (2022)

Electrophysiological Manifestations of Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review
por: Hartnett, Jack, et al.
Publicado: (2021)

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review
por: Gervaso, Lorenzo, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review
por: Tan, Sean, et al.
Publicado: (2022)

Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Bhatia, Smita
Publicado: (2020)

The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
por: Omland, Torbjørn, et al.
Publicado: (2022)

Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review
por: Welty, Nathan E., et al.
Publicado: (2022)

Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review
por: Leiva, Orly, et al.
Publicado: (2021)

21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine
por: Sheng, Calvin Chen, et al.
Publicado: (2016)

ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review
por: Griffin, Jan M., et al.
Publicado: (2021)

Screening for Coronary Artery Disease in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Velusamy, Ragani, et al.
Publicado: (2023)

Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: JACC: CardioOncology State-of-the-Art Review
por: Leong, Darryl P., et al.
Publicado: (2023)

Implementation of National Health Policy for the Prevention and Control of Cardiovascular Disease in South Korea: Regional-Local Cardio-Cerebrovascular Center and Nationwide Registry
por: Wang, Ju Mee, et al.
Publicado: (2021)

AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review
por: Bianchi, Giada, et al.
Publicado: (2021)

Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review
por: Suero-Abreu, Giselle Alexandra, et al.
Publicado: (2022)

Opportunities to improve cardiovascular health in the new American workplace
por: Duffy, Eamon Y., et al.
Publicado: (2020)

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
por: Abovich, Arielle, et al.
Publicado: (2023)

Cardiovascular risk assessment: The foundation of preventive cardiology
por: Wong, Nathan D.
Publicado: (2020)

Sarcopenia and Cardiovascular Diseases
por: Damluji, Abdulla A., et al.
Publicado: (2023)

Lifestyle Modification in the Management of Metabolic Syndrome: Statement From Korean Society of CardioMetabolic Syndrome (KSCMS)
por: Kim, Hack-Lyoung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5lneo11hpmoupq4ad2le1tvope